Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GA.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.6.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.6.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.6.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.6.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.44.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.44.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.44.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.44.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.44.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.44.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.44.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.44.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FL.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.37ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.37EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.45.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.45.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.45.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.45.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.45.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.45.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.45.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.45.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FP.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FP.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FP.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FP.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FP.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FP.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used